{"success":true,"data":{"pressRelease":{"id":"45031","rtpr_id":"nNFCc75TH0","ticker":"ADIA","exchange":"OTC","all_tickers":["ADIA"],"title":"Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry","author":"Newsfile Corp","published_at":"2026-05-26T12:00:12.963Z","article_body":"Winter Park, Florida--(Newsfile Corp. - May 26, 2026) - Adia Nutrition Inc.\n(OTCQB: ADIA), a publicly traded company advancing regenerative medicine and\ninnovative healthcare solutions, today announced that an independent\nmonthly-membership health care sharing ministry — where members pay monthly\ndues as an alternative to traditional health insurance — now accepts up to\nthree stem cell treatments per client.\n\nThis expanded coverage provides eligible members with greater access to\nadvanced stem cell therapies for regenerative applications. A family of three\nis currently undergoing treatment with AdiaVita at one of the company's\naffiliate clinics, demonstrating the real-world impact of this new benefit.\n\nThe health care sharing ministry serves more than 250,000 members nationwide.\nAdia Nutrition continues to enhance access to cutting-edge regenerative\ntherapies through partnerships with such monthly-membership plans. Adia Med\nwill continue reaching out to other health care sharing programs to further\nbroaden access to these advanced regenerative therapies for more members\nnationwide.\n\n\"By covering up to three treatments per client, we are removing barriers and\nempowering families to pursue comprehensive regenerative care,\" said Larry\nPowalisz, CEO of Adia Nutrition. \"This milestone reflects our commitment to\npatient-centered innovation and expanding access to high-quality stem cell\nsolutions like AdiaVita.\"\n\nFor questions, inquiries, or additional information, please contact Larry\nPowalisz at ceo@adiamed.com or by phone at 321-788-0850.\n\nAbout ADIA Nutrition Inc.:\nAdia Nutrition Inc. (OTCQB: ADIA), based in Winter Park, Florida, is a\npublicly traded company advancing healthcare through innovation. The company\nspecializes in sales of stem cell and regenerative products, such as AdiaVita\nand AdiaLink, through its lab division, Adia Labs LLC, which is expanding to\ninclude insurance-billable wound care products. Adia is also growing\nnationwide with Adia Med clinics, specializing in orthopedic, pain management,\nand wound repair. Adia Med clinics also offer specialized regenerative\ntreatments like stem cell therapies and platelet-rich plasma (PRP), advanced\ntreatments including therapeutic plasma exchange (TPE) and autologous\nhematopoietic stem cell transplantation (aHSCT), and wound repair services.\n\nRevenue is generated through service fees, product sales, equity stakes, and\nbilling insurance for healthcare treatments. Additionally, Adia Nutrition Inc.\ninvests in aligned businesses such as Cement Factory LLC, a nutrition and\nsupplement company with shared values and a focus on health and wellness.\nThrough bold partnerships with top-tier medical entities and unwavering\ndedication to standardized, FDA-approved lab protocols, Adia Nutrition Inc. is\nrevolutionizing healthcare, igniting a nationwide movement to empower\ncommunities with groundbreaking regenerative solutions and vibrant, holistic\nwellness.\n\nWebsite: www.adianutrition.com\nWebsite: www.adiamed.com\nWebsite: www.adialabs.com\nWebsite: www.cementfactory.co\nTwitter (X): @ADIA_Nutrition\n\nSafe Harbor: This Press Release contains forward-looking statements within the\nmeaning of Section 27A of the Securities Act of 1933 and Section 21E of the\nSecurities Exchange Act of 1934. These forward-looking statements are based on\nthe current plans and expectations of management and are subject to a few\nuncertainties and risks that could significantly affect the company's current\nplans and expectations, as well as future results of operations and financial\ncondition. A more extensive listing of risks and factors that may affect the\ncompany's business prospects and cause actual results to differ materially\nfrom those described in the forward-looking statements can be found in the\nreports and other documents filed by the company with the Securities and\nExchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The\ncompany undertakes no obligation to publicly update or revise any\nforward-looking statements, because of new information, future events or\notherwise.\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/298761","article_body_html":"","raw_payload":{"data":{"id":"nNFCc75TH0","title":"Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry","author":"Newsfile Corp","ticker":"ADIA","created":"2026-05-26T12:00:12.963Z","tickers":["ADIA"],"exchange":"OTC","article_body":"Winter Park, Florida--(Newsfile Corp. - May 26, 2026) - Adia Nutrition Inc.\n(OTCQB: ADIA), a publicly traded company advancing regenerative medicine and\ninnovative healthcare solutions, today announced that an independent\nmonthly-membership health care sharing ministry — where members pay monthly\ndues as an alternative to traditional health insurance — now accepts up to\nthree stem cell treatments per client.\n\nThis expanded coverage provides eligible members with greater access to\nadvanced stem cell therapies for regenerative applications. A family of three\nis currently undergoing treatment with AdiaVita at one of the company's\naffiliate clinics, demonstrating the real-world impact of this new benefit.\n\nThe health care sharing ministry serves more than 250,000 members nationwide.\nAdia Nutrition continues to enhance access to cutting-edge regenerative\ntherapies through partnerships with such monthly-membership plans. Adia Med\nwill continue reaching out to other health care sharing programs to further\nbroaden access to these advanced regenerative therapies for more members\nnationwide.\n\n\"By covering up to three treatments per client, we are removing barriers and\nempowering families to pursue comprehensive regenerative care,\" said Larry\nPowalisz, CEO of Adia Nutrition. \"This milestone reflects our commitment to\npatient-centered innovation and expanding access to high-quality stem cell\nsolutions like AdiaVita.\"\n\nFor questions, inquiries, or additional information, please contact Larry\nPowalisz at ceo@adiamed.com or by phone at 321-788-0850.\n\nAbout ADIA Nutrition Inc.:\nAdia Nutrition Inc. (OTCQB: ADIA), based in Winter Park, Florida, is a\npublicly traded company advancing healthcare through innovation. The company\nspecializes in sales of stem cell and regenerative products, such as AdiaVita\nand AdiaLink, through its lab division, Adia Labs LLC, which is expanding to\ninclude insurance-billable wound care products. Adia is also growing\nnationwide with Adia Med clinics, specializing in orthopedic, pain management,\nand wound repair. Adia Med clinics also offer specialized regenerative\ntreatments like stem cell therapies and platelet-rich plasma (PRP), advanced\ntreatments including therapeutic plasma exchange (TPE) and autologous\nhematopoietic stem cell transplantation (aHSCT), and wound repair services.\n\nRevenue is generated through service fees, product sales, equity stakes, and\nbilling insurance for healthcare treatments. Additionally, Adia Nutrition Inc.\ninvests in aligned businesses such as Cement Factory LLC, a nutrition and\nsupplement company with shared values and a focus on health and wellness.\nThrough bold partnerships with top-tier medical entities and unwavering\ndedication to standardized, FDA-approved lab protocols, Adia Nutrition Inc. is\nrevolutionizing healthcare, igniting a nationwide movement to empower\ncommunities with groundbreaking regenerative solutions and vibrant, holistic\nwellness.\n\nWebsite: www.adianutrition.com\nWebsite: www.adiamed.com\nWebsite: www.adialabs.com\nWebsite: www.cementfactory.co\nTwitter (X): @ADIA_Nutrition\n\nSafe Harbor: This Press Release contains forward-looking statements within the\nmeaning of Section 27A of the Securities Act of 1933 and Section 21E of the\nSecurities Exchange Act of 1934. These forward-looking statements are based on\nthe current plans and expectations of management and are subject to a few\nuncertainties and risks that could significantly affect the company's current\nplans and expectations, as well as future results of operations and financial\ncondition. A more extensive listing of risks and factors that may affect the\ncompany's business prospects and cause actual results to differ materially\nfrom those described in the forward-looking statements can be found in the\nreports and other documents filed by the company with the Securities and\nExchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The\ncompany undertakes no obligation to publicly update or revise any\nforward-looking statements, because of new information, future events or\notherwise.\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/298761"},"type":"article","timestamp":"2026-05-26T12:00:13.020602473Z","server_sent_at_ms":1779796813020},"received_at":"2026-05-26T12:00:13.121Z","source_url":"https://www.newsfilecorp.com/release/298761"},"analysis":{"id":"34465","press_release_id":"45031","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"partnership","narrative":"Adia Nutrition announced that an independent health care sharing ministry with over 250,000 members now covers up to three stem cell treatments per client.\n\nThis expanded coverage aims to remove barriers for families seeking regenerative care, with a family of three already undergoing treatment with AdiaVita at an affiliate clinic.\n\nAdia Med plans to reach out to other health care sharing programs to further broaden access to these advanced therapies nationwide.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Adia expands stem cell access via health sharing ministry covering up to 3 treatments per client."},"keyFigures":{"customDimensions":{"ministry_members":250000,"treatments_per_client":3}},"quotedText":"By covering up to three treatments per client, we are removing barriers and empowering families to pursue comprehensive regenerative care","namedEntities":{"people":[{"name":"Larry Powalisz","role":"CEO"}],"products":["AdiaVita","AdiaLink","stem cell treatments","platelet-rich plasma (PRP)","therapeutic plasma exchange (TPE)","autologous hematopoietic stem cell transplantation (aHSCT)"],"companies":[{"name":"Adia Nutrition Inc.","ticker":"ADIA"},{"name":"Adia Med","relationship":"subsidiary"},{"name":"Adia Labs LLC","relationship":"subsidiary"},{"name":"Cement Factory LLC","relationship":"investee"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"The announcement of expanded coverage for stem cell treatments through a health care sharing ministry is a positive operational update that enhances access to Adia's therapies. However, it is a routine partnership expansion rather than a transformative event like a major FDA approval or large-scale M&A, warranting a moderate impact score."},"tickerRelevance":{"others":[],"primary":"ADIA"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":["operations_update"],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"operational_partnership","sectorWeight":"healthcare","householdBrandBoost":0,"marketCapAdjustment":"low","retailFavoriteBoost":0}},"event_type":"partnership","event_type_secondary":["operations_update"],"sentiment":"bullish","material_impact_score":2,"narrative":"Adia Nutrition announced that an independent health care sharing ministry with over 250,000 members now covers up to three stem cell treatments per client.\n\nThis expanded coverage aims to remove barriers for families seeking regenerative care, with a family of three already undergoing treatment with AdiaVita at an affiliate clinic.\n\nAdia Med plans to reach out to other health care sharing programs to further broaden access to these advanced therapies nationwide.","key_figures":{"customDimensions":{"ministry_members":250000,"treatments_per_client":3}},"named_entities":{"people":[{"name":"Larry Powalisz","role":"CEO"}],"products":["AdiaVita","AdiaLink","stem cell treatments","platelet-rich plasma (PRP)","therapeutic plasma exchange (TPE)","autologous hematopoietic stem cell transplantation (aHSCT)"],"companies":[{"name":"Adia Nutrition Inc.","ticker":"ADIA"},{"name":"Adia Med","relationship":"subsidiary"},{"name":"Adia Labs LLC","relationship":"subsidiary"},{"name":"Cement Factory LLC","relationship":"investee"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-26T12:09:35.467Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"micro-cap","eventGravity":"operational_partnership","sectorWeight":"healthcare","householdBrandBoost":0,"marketCapAdjustment":"low","retailFavoriteBoost":0}},"durationMs":18539,"modelName":"george-droid-qwen-72b"}}